Severe sepsis common and costly in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.331, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADEs common, costly and largely preventable in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 325, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Febrile neutropenia costly in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

GORD costly to US employers

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Cetuximab-related IRs common and costly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 599, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Immunopathogenesis of severe sepsis

By Noursadeghi Mahdad Cohen Jonathan

Clinical Medicine, Vol. 34, Iss. 5, 2000-09 ,pp. : 432-436

Royal College Of Physicians

Access to resources Recommend Favorite